Wegovy Pill
The Wegovy pill is a new oral form of Wegovy containing the active ingredient semaglutide. In official medical contexts, the term Wegovy tablets or oral Wegovy formulation is mainly used. The term “Wegovy pill” is currently used above all in media coverage and search queries.
This refers to a tablet form of Wegovy that is not injected, but taken orally. Unlike the Wegovy injection, the new dosage form is intended for daily intake.
The Wegovy tablet is intended for medical weight loss in adults with obesity or overweight and weight-related comorbidities. Like other weight loss medications, it should only be used after medical assessment and alongside nutrition, physical activity and lifestyle measures.
The oral Wegovy formulation has been recommended in Europe by the European Medicines Agency for an extension of the existing Wegovy approval. The final decision will be made by the European Commission. Therefore, when the Wegovy tablet will become available in Germany and which name will be used officially in Germany should be checked once the final product information has been published.
Who Is the Wegovy Pill Suitable For?
The Wegovy tablet may generally be suitable for adults with obesity or for adults with overweight and at least one weight-related comorbidity. These may include type 2 diabetes, high blood pressure, elevated blood lipid levels, cardiovascular disease or sleep apnea.
Body weight alone is not the only deciding factor. Whether treatment with semaglutide is medically appropriate should always be assessed by a doctor. Relevant factors include pre-existing conditions, other medications, previous weight loss attempts and potential risks.
Like other medications for weight loss, the Wegovy pill is not intended for short-term cosmetic weight loss. Treatment is intended as part of a medically supervised treatment concept that includes nutrition, physical activity and lifestyle measures.
What Is the Wegovy Tablet Intended For?
The Wegovy tablet is intended for medical weight loss and long-term weight management. It is designed to help adults reduce body weight and better maintain the weight loss achieved, provided the medical requirements are met.
Unlike over-the-counter diet products, Wegovy is a prescription-only medication. Treatment should therefore only take place after medical assessment and with regular medical supervision.
It is also important to understand that the oral Wegovy formulation does not replace lifestyle changes. It is used alongside a calorie-conscious diet and increased physical activity. You can find an overview of medically supervised weight loss at The Body Clinic on our page about weight loss with medical supervision.
How Does the Wegovy Tablet Work?
The Wegovy tablet contains the active ingredient semaglutide. Semaglutide is a GLP-1 receptor agonist. It mimics the effect of a natural gut hormone involved in the regulation of appetite, satiety and blood sugar.
Through this mechanism, semaglutide may help reduce hunger, prolong the feeling of fullness and support a lower calorie intake in everyday life. This can support weight loss when treatment is combined with nutrition, physical activity and behavioral changes.
The active ingredient is already known from the Wegovy injection. The key difference is the dosage form: the Wegovy injection is administered once weekly, while the new Wegovy tablet is taken daily.
How Is the Wegovy Pill Taken?
The Wegovy tablet is intended as an oral alternative to the weekly injection. According to current EMA information, it is taken once daily on an empty stomach, after at least eight hours of fasting. After taking it, patients should not eat, drink or take any other medication for 30 minutes.
This intake routine is important because semaglutide in tablet form can only be absorbed sufficiently under specific conditions. Patients should therefore follow their doctor’s instructions carefully and should not change the dose on their own.
Dosage
The exact dosage and possible dose escalation of the Wegovy tablet should be determined individually by a doctor. Important factors include the patient’s starting situation, tolerability, comorbidities and possible interactions with other medications.
As long as the final product information for Germany has not yet been published, information about available doses, pack sizes and the exact dosing schedule should be treated with particular caution. The most important point for patients is: no use without a medical prescription and no independent dose adjustment.
Taking It in Everyday Life
For many people, a tablet may seem easier to integrate into daily life than an injection. At the same time, daily intake comes with clear rules. Anyone taking other medications should therefore discuss with a doctor how the Wegovy tablet could be safely integrated into their daily routine.
Whether the tablet form or another treatment option is more suitable depends on the individual situation. In addition to Wegovy, other treatment options such as Mounjaro, Saxenda or other weight loss medications may be considered.
Your Journey to Sustainable Weight Loss Starts Here.
Who Developed the Wegovy Pill?
The Wegovy tablet comes from the pharmaceutical company Novo Nordisk. Novo Nordisk is also the marketing authorisation holder for Wegovy and is responsible for the already known Wegovy injection.
Both dosage forms contain the active ingredient semaglutide. The main difference lies in how they are used: the Wegovy injection is administered once weekly, while the Wegovy tablet is intended as a daily oral form.
Manufacturer
Novo Nordisk is an international pharmaceutical company with a focus on metabolic diseases such as diabetes and obesity. In addition to Wegovy, well-known medicines from the manufacturer include Ozempic and Rybelsus.
Availability in Germany
The oral Wegovy formulation has been recommended in Europe for an extension of the existing Wegovy approval. However, the final decision on the approval extension will be made by the European Commission. Only after that will it be possible to reliably assess when and under which conditions the Wegovy tablet will become available in Germany.
For patients, this means that the Wegovy tablet is an important new development in medical weight loss. At present, however, it should still be assessed individually by a doctor which already available medications for weight loss may be suitable.
Where Can I Buy the Wegovy Pill?
The Wegovy tablet is intended as a prescription-only medication and should not be used without a medical prescription. Buying it freely without a prescription or through unreliable online shops is not recommended from a medical perspective.
As long as the Wegovy tablet is not yet routinely available in Germany, it also cannot be planned as an already available treatment option. Whether treatment with semaglutide is generally suitable should always be decided as part of a medical consultation.
At The Body Clinic, you can have your personal suitability for medically supervised weight loss assessed. Depending on your individual situation, already available options such as Wegovy as an injection, Mounjaro or Saxenda may be discussed.
What Are Possible Side Effects?
Like other GLP-1 medications, the Wegovy tablet can cause side effects. These most commonly affect the gastrointestinal tract. They may include nausea, diarrhoea, constipation, abdominal pain, indigestion and vomiting.
These symptoms often occur at the beginning of treatment. Whether side effects occur and how severe they are varies from person to person. Medical supervision is therefore important, especially if symptoms persist, become more severe or cause uncertainty.
Common Side Effects
- Nausea
- Diarrhoea
- Constipation
- Abdominal pain
- Indigestion
- Vomiting
You can also find more information on the tolerability of GLP-1 therapies on our page about medications for weight loss.
Rare or Serious Warning Signs
In rare cases, symptoms may occur during GLP-1 therapy that should be assessed promptly by a doctor. These include, for example, severe or persistent abdominal pain, repeated vomiting, signs of dehydration, allergic reactions or unusual upper abdominal symptoms.
Patients should not simply “put up with” side effects, but should have them medically assessed. This is particularly important in the case of pre-existing conditions, multiple medications or previous intolerances.
What Is Important Regarding Safety, Interactions and Contraindications?
The Wegovy tablet is not a lifestyle product, but a prescription-only medication. Before treatment, a doctor should assess whether semaglutide is suitable for the patient’s personal health situation.
Interactions
Because the Wegovy tablet should be taken on an empty stomach and with a time interval before eating, drinking or taking other medicines, possible interactions and intake intervals are particularly important. Anyone who regularly takes medication should therefore always discuss its use with a doctor.
This applies in particular to diabetes medications, blood pressure medication, medicines with a narrow therapeutic range or preparations that must be taken at specific times of the day.
Contraindications and Special Precautions
Not every patient is suitable for treatment with semaglutide. Particular caution may be required, for example, in certain gastrointestinal conditions, pancreatic disease, serious pre-existing conditions, pregnancy, breastfeeding or planned pregnancy.
Whether the Wegovy tablet, the Wegovy injection or another medication is appropriate should always be decided individually. The aim is not only weight loss, but a safe, medically supervised and sustainable treatment approach.
Medical Weight Loss in Berlin, Munich, Hamburg, Frankfurt, or online.
How Much Weight Can You Lose With the Wegovy Tablet?
The possible weight loss with the Wegovy tablet depends strongly on the individual starting situation. Important factors include starting weight, comorbidities, nutrition, physical activity, tolerability and adherence to treatment.
In the phase 3 study cited by the EMA, patients taking Wegovy tablets lost an average of 13.61 percent of their body weight after 64 weeks. In the placebo group, the average weight loss was 2.18 percent. Treatment was provided alongside a reduced-calorie diet and increased physical activity.
Important: the Wegovy pill is not a substitute for a structured treatment concept. Sustainable weight loss is most likely when the medication is combined with medical supervision, nutrition, physical activity and long-term behavioral changes.
How Does the Wegovy Tablet Differ From Other Medications?
Like the Wegovy injection, the Wegovy tablet belongs to the group of medications containing the active ingredient semaglutide. The main difference is the dosage form: the tablet is taken daily, while the injection is administered once weekly.
When comparing it with other medications for weight loss, the key questions are which active ingredient is used, how the medication is administered and which patients it may be medically suitable for.
Wegovy Pill vs. Wegovy Injection
The term Wegovy pill refers to the new Wegovy tablet. Both forms contain semaglutide. The injection is administered under the skin once weekly. The tablet, by contrast, is intended for daily oral intake.
For some patients, a tablet may feel more convenient than an injection. At the same time, oral intake requires strict instructions, such as taking the tablet on an empty stomach and keeping a time interval before eating, drinking or taking other medication. Which form is more suitable should be decided individually by a doctor.
Wegovy Tablet vs. Ozempic
Ozempic also contains semaglutide, but it is primarily a medication for the treatment of type 2 diabetes. Wegovy, by contrast, is specifically intended for medical weight loss.
Even though both medications contain the same active ingredient, they should not be considered interchangeable. Approval, dosage, application and medical treatment goals differ.
Wegovy Tablet vs. Rybelsus
Rybelsus is an already known semaglutide tablet for the treatment of type 2 diabetes. The Wegovy tablet, by contrast, is intended as an oral semaglutide formulation for medical weight loss.
The difference therefore lies not only in the dosage form, but above all in the approved use, dosage and therapeutic goal.
Wegovy Tablet vs. Mounjaro
Mounjaro contains the active ingredient tirzepatide. Tirzepatide acts not only on the GLP-1 receptor, but also on the GIP receptor. This clearly distinguishes Mounjaro from semaglutide-based medications such as Wegovy.
Mounjaro is administered as an injection. Whether Mounjaro, Wegovy as an injection or, in the future, a Wegovy tablet may be more suitable depends on the individual medical situation.
Wegovy Tablet vs. Saxenda
Saxenda contains the active ingredient liraglutide. Liraglutide also belongs to the GLP-1 receptor agonists, but it is dosed and administered differently from semaglutide.
While Saxenda is used as a daily injection, the Wegovy tablet is intended for daily oral intake. Both medications should only be used after medical assessment and as part of a structured treatment concept.
How Much Does the Wegovy Tablet Cost?
The cost of the Wegovy tablet in Germany cannot yet be stated reliably. As long as the final approval extension, specific market launch, pack sizes and pharmacy prices have not been confirmed, no fixed price information should be given.
In general, the cost of weight loss medications depends on several factors: dosage, pack size, treatment duration, medical supervision and possible reimbursement. As soon as reliable information for Germany becomes available, this section should be updated.
You can find information about our treatment concept and current program costs on our page about prices for medical weight loss.
Will Health Insurance Cover the Wegovy Tablet?
Whether and to what extent the Wegovy tablet will be reimbursed in Germany has not yet been conclusively clarified. After a European approval, questions about price and reimbursement are decided at the level of the individual Member States.
For patients, this means that possible approval does not automatically mean that the costs will be covered by statutory or private health insurance. Actual reimbursement depends on the applicable legal framework, insurance conditions and the individual medical situation.
You can find more general information on this topic on our page about health insurance and weight loss medications.
How Can I Stop Taking the Wegovy Tablet?
The Wegovy tablet should not be stopped or changed in dosage independently. Anyone experiencing side effects, feeling uncertain or wanting to end treatment should always discuss this with a doctor.
After stopping weight loss medications, weight can increase again, especially if nutrition, physical activity and everyday routines have not been stabilized long term. A supportive plan is therefore important in order to maintain the weight loss achieved as effectively as possible.
At The Body Clinic, the focus is therefore not only on the medication itself, but on a medically supervised program. The aim is a treatment approach that fits the personal situation and remains sustainable in the long term.
Is Wegovy Available as a Pill?
Yes, there is a new oral form of Wegovy containing the active ingredient semaglutide. In medical contexts, it is mainly referred to as Wegovy tablets or an oral Wegovy formulation. The term “Wegovy pill” is currently often used in search queries and in media coverage.
Is the Wegovy Tablet Already Available in Germany?
As of now, the Wegovy tablet is not yet routinely available in Germany. The European Medicines Agency and the CHMP have recommended extending the existing Wegovy approval to include an oral formulation. The final decision will be made by the European Commission.
When Will the Wegovy Pill Come to Germany?
An exact date for routine availability in Germany has not yet been reliably confirmed publicly. Following the positive EMA recommendation, market introduction could follow soon. This section should be updated as soon as official information on the German launch becomes available.
What Active Ingredient Does the Wegovy Tablet Contain?
The Wegovy tablet contains semaglutide. Semaglutide is a GLP-1 receptor agonist and is also used in the well-known Wegovy injection. The main difference lies in the dosage form and how it is used.
How Does the Wegovy Tablet Work?
Semaglutide may reduce hunger and prolong the feeling of fullness. This can make it easier to consume fewer calories in everyday life. Treatment should always be combined with nutrition, physical activity and medical supervision.
How Is the Wegovy Pill Taken?
The Wegovy tablet is intended for daily intake. According to current EMA information, it should be taken on an empty stomach, with a time interval before eating, drinking or taking other medications. The exact use should always follow medical instructions.
What Is the Difference Between the Wegovy Tablet and the Wegovy Injection?
Both dosage forms contain the active ingredient semaglutide. The Wegovy injection is administered once a week. The Wegovy tablet, by contrast, is taken orally every day. Which form is more suitable depends on the individual medical situation, tolerability and personal preferences.
Who Is the Wegovy Tablet Suitable For?
The Wegovy tablet may generally be suitable for adults with obesity or for adults with overweight and at least one weight-related comorbidity. Whether treatment is appropriate must always be assessed by a doctor.
Can You Buy the Wegovy Pill Without a Prescription?
No. The Wegovy tablet is intended as a prescription-only medication. Buying it without a prescription or through unreliable online offers is not recommended from a medical perspective.
What Side Effects Can the Wegovy Tablet Cause?
Like other GLP-1 medications, the Wegovy tablet can cause side effects. These commonly affect the gastrointestinal tract, for example nausea, diarrhoea, constipation, abdominal pain, indigestion or vomiting. Medical advice should be sought if symptoms are severe or persistent.
Is the Wegovy Pill Better Than the Injection?
There is no general answer to this. For some patients, a tablet may be more convenient than an injection. At the same time, the tablet must be taken daily and according to specific intake instructions. Which treatment form is more suitable should be decided individually.
How Much Does the Wegovy Tablet Cost?
The cost of the Wegovy tablet in Germany is not yet reliably known. Prices depend, among other things, on approval, market launch, pack size, dosage and reimbursement rules.
Will Health Insurance Cover the Wegovy Pill?
Whether statutory or private health insurance providers will reimburse the Wegovy tablet has not yet been conclusively clarified. Approval does not automatically mean that the costs will be covered. Reimbursement depends on the applicable rules and the individual insurance contract.
Can I Already Start Treatment With the Wegovy Tablet at The Body Clinic?
Sources
- European Medicines Agency (EMA). First oral GLP-1 treatment for weight management. Published on 22 May 2026. View announcement .
- European Medicines Agency (EMA). Wegovy: EPAR – Medicine Overview and Product Information. View document .
- Novo Nordisk. News Details on the Wegovy Pill / Oral Wegovy Formulation. View press release .
- Reuters. EMA backs Novo’s Wegovy pill, first oral weight-loss drug for Europe. Published on 22 May 2026. View article .